Difficulty: Medium
Average Score: 79%
Practice
A 25-year-old man with multiple sexual partners begins to have flulike symptoms. He visits his primary care physician who recommends an HIV screening test based on his history. He is found to have an HIV infection and begins a drug regimen. Which of the following works by blocking the cleavage of the HIV polyproteins?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Darunavir. Darunavir belongs to a class of HIV drugs known as protease inhibitors, which work by blocking the cleavage of the HIV polyproteins, preventing the virus from maturing and infecting new cells. This action helps to reduce the viral load in the body and slow down the progression of HIV.
Option B) Delavirdine is a non-nucleoside reverse transcriptase inhibitor that works by targeting a different enzyme in the HIV life cycle, the reverse transcriptase enzyme. Option C) Enfuvirtide is a fusion inhibitor that works by preventing HIV from entering human cells. Option D) Maraviroc is a CCR5 antagonist that works by blocking HIV entry into CD4 cells.
In an educational context, understanding how different classes of HIV drugs work is crucial for healthcare professionals involved in the treatment and management of HIV/AIDS patients. Knowing the mechanisms of action of these drugs helps in making informed decisions about the most appropriate treatment regimens for individual patients based on factors such as viral resistance profiles and potential drug interactions.
Option B) Delavirdine is a non-nucleoside reverse transcriptase inhibitor that works by targeting a different enzyme in the HIV life cycle, the reverse transcriptase enzyme. Option C) Enfuvirtide is a fusion inhibitor that works by preventing HIV from entering human cells. Option D) Maraviroc is a CCR5 antagonist that works by blocking HIV entry into CD4 cells.
In an educational context, understanding how different classes of HIV drugs work is crucial for healthcare professionals involved in the treatment and management of HIV/AIDS patients. Knowing the mechanisms of action of these drugs helps in making informed decisions about the most appropriate treatment regimens for individual patients based on factors such as viral resistance profiles and potential drug interactions.